Cell therapy’s next chapter: Industry embraces in-vivo innovation Nikhil C Bhanumathi Sep 15, 2025 Nikhil C Bhanumathi, Principal Clinical Lead, Thermo Fisher Scientific highlights that Cell therapy is entering a bold new phase…
FDA approves Tecartus, cell-based gene therapy to treat relapsed or refractory MCL in adults EP News Bureau Jul 25, 2020 It also received ‘Orphan Drug’ designation, which provides incentives to assist and encourage the development of drugs for rare…
Cancer CART therapy: What are the benefits and stakes? EP News Bureau Jun 13, 2020 Debamita Chatterjee, Ex-researcher, Harvard Medical School and NYAS/MIT/European Commission Innovation Mentor elaborates how…
